Abstract

Renal dysfunction is among the most common complication of sickle cell disease (SCD), from hyposthenuria in children to progression to overt chronic kidney disease (CKD) in young adults. Emerging evidence now suggests that sickle hemoglobin-related nephropathy extends to individuals with sickle cell trait (SCT). Areas covered: This review will highlight the pathophysiology, epidemiology, and management recommendations for sickle hemoglobin-related nephropathy in both SCD and SCT. In addition, it will focus on the major demographic and genetic modifiers of renal disease in sickling hemoglobinopathies. Expert commentary: Studies have elucidated the course of renal disease in SCD; however, the scope and age of onset of renal dysfunction in SCT has yet to be determined. In SCD, several modifiers of renal disease - such as α-thalassemia, hemoglobin F, APOL1 and HMOX1 - have been described and provide an opportunity for a precision medicine approach to risk stratify patients who may benefit from early intervention. Extrapolating from this literature may also provide insight into the modifiers of renal disease in SCT. Further studies are needed to determine the optimal treatment for sickle hemoglobin-related nephropathy.

MeSH

Hemoglobinopathies, Hematologic Diseases, Anemia, Sickle Cell, Cells, Precision Medicine, Sickle Cell Trait, Hemoglobins, Hemoglobin, Sickle

Cited by

• Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait. Clin J Am Soc Nephrol, 2023
• Multifactorial Origin of Exertional Rhabdomyolysis, Recurrent Hematuria, and Episodic Pain in a Service Member with Sickle Cell Trait. Case Rep Genet, 2018
• Genetics and ESKD Disparities in African Americans. Am J Kidney Dis, 2020
• Do We Store Packed Red Blood Cells under "Quasi-Diabetic" Conditions? Biomolecules, 2021
• Chronic kidney disease in adults with sickle cell trait: a systematic review and meta-analysis. Blood Adv, 2025
• Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease. Haematologica, 2022
• Factors Associated with Microalbuminuria among Children with Sickle Cell Disease in a Tertiary Centre in South-South Nigeria. Niger Med J, 2025
• Renal Functional Decline in Sickle Cell Disease and Trait. J Am Soc Nephrol, 2020
• Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events? Blood Adv, 2021
• Non-S Sickling Hemoglobin Variants: Historical, Genetic, Diagnostic, and Clinical Perspectives. Oman Med J, 2021
• Hyponatremia in Patients with Hematologic Diseases. J Clin Med, 2020
• Sickle cell nephropathy: A review of novel biomarkers and their potential roles in early detection of renal involvement. World J Clin Pediatr, 2022
• Pregnancy in sickle cell trait: what we do and don't know. Br J Haematol, 2021
• Renal Risk Variants and Sickle Cell Trait Associations With Reduced Kidney Function in a Large Congolese Population-Based Study. Kidney Int Rep, 2022
• Mortality trends in sickle cell patients. Am J Blood Res, 2020
• Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients. Pediatr Nephrol, 2021
• VEGF Promoter Region 18-bp Insertion-Deletion Polymorphism in Sickle Cell Disease Patients with Microalbuminuria: A Pilot Study. Indian J Hematol Blood Transfus, 2019
• Sickle cell trait and renal disease among African American U.S. Army soldiers. Br J Haematol, 2020
• Incidental Findings of Sickle Cell Trait From an Everyday Diabetes Test: Should General Health Care Providers and Testing Centers Report, Retest, or Refer? Clin Diabetes, 2020
• Vignette-Based Reflections to Inform Genetic Testing Policies in Living Kidney Donors. Genes (Basel), 2022